Literature DB >> 31223449

DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.

Keisuke Tomohara1, Isao Adachi2, Yoshikazu Horino3, Hitoshi Kesamaru4, Hitoshi Abe3, Keitaro Suyama1, Takeru Nose1,4.   

Abstract

In search for enzyme inhibitors, we often encounter "promiscuous" enzyme inhibitors exhibiting nonspecific binding property toward enzyme active site. Therefore, inhibitory candidates should be mechanistically characterized as early as possible in discovery processes. However, there remains a lack of highly reliable and readily available methodology to evaluate specificity of initial hits inhibitors. The present study developed and established a novel DMSO-perturbing assay to identify promiscuous enzyme inhibitors. The assay successfully identified nonspecific binding inhibitors with a broad scope, typically by the attenuation of inhibitory activity by the influence of DMSO-addition. This attenuation would be attributed to the nonspecific binding property of inhibitors toward both productive and nonproductive (nondenatured) states of enzymes in perturbation solution. This working hypothesis was supported by spectroscopic analyses of enzyme conformations and analyses of solvent effects on perturbation. Overall, these results provided a novel concept of the DMSO-perturbing assay.

Entities:  

Year:  2019        PMID: 31223449      PMCID: PMC6580536          DOI: 10.1021/acsmedchemlett.9b00093

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  Development of a virtual screening method for identification of "frequent hitters" in compound libraries.

Authors:  Olivier Roche; Petra Schneider; Jochen Zuegge; Wolfgang Guba; Manfred Kansy; Alexander Alanine; Konrad Bleicher; Franck Danel; Eva-Maria Gutknecht; Mark Rogers-Evans; Werner Neidhart; Henri Stalder; Michael Dillon; Eric Sjögren; Nader Fotouhi; Paul Gillespie; Robert Goodnow; William Harris; Phil Jones; Mikio Taniguchi; Shinji Tsujii; Wolfgang von der Saal; Gerd Zimmermann; Gisbert Schneider
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

2.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

3.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

Authors:  Robert A Copeland
Journal:  Methods Biochem Anal       Date:  2005

4.  Beta-II conformation of all-beta proteins can be distinguished from unordered form by circular dichroism.

Authors:  J Wu; J T Yang; C S Wu
Journal:  Anal Biochem       Date:  1992-02-01       Impact factor: 3.365

5.  A detergent-based assay for the detection of promiscuous inhibitors.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.

Authors:  Kristin E D Coan; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2008-06-28       Impact factor: 15.419

7.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

8.  Design of serine protease inhibitors with conformation restricted by amino acid side-chain-side-chain CH/pie interaction.

Authors:  Y Shimohigashi; T Nose; Y Yamauchi; I Maeda
Journal:  Biopolymers       Date:  1999       Impact factor: 2.505

9.  Effect of the addition of a nonaqueous polar solvent (glycerol) on enzymatic catalysis in reverse micelles. Hydrolysis of 2-naphthyl acetate by alpha-chymotrypsin.

Authors:  R Darío Falcone; M Alicia Biasutti; N Mariano Correa; Juana J Silber; Eduardo Lissi; Elsa Abuin
Journal:  Langmuir       Date:  2004-07-06       Impact factor: 3.882

10.  Synthetic analogues of chymostatin. Inhibition of chymotrypsin and Streptomyces griseus proteinase A.

Authors:  N P Tomkinson; I J Galpin; R J Beynon
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

View more
  1 in total

1.  Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO.

Authors:  Gabriel Jiménez-Avalos; A Paula Vargas-Ruiz; Nicolás E Delgado-Pease; Gustavo E Olivos-Ramirez; Patricia Sheen; Manolo Fernández-Díaz; Miguel Quiliano; Mirko Zimic
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.